N-acetylcysteine abolishes the protective effect of losartan against left ventricular remodeling in cardiomyopathy hamster

Antioxidants and Redox Signaling

Volumn 10, Issue 12, 2008, Pages 1999-2008

  Matsuhisa, Seiji ^a   Otani, Hajime ^a   Okazaki, Toru ^a   Yamashita, Koji ^a   Akita, Yuzo ^a   Sato, Daisuke ^a   Moriguchi, Akira ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LOSARTAN; N(G) NITROARGININE METHYL ESTER; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; HEART LEFT VENTRICLE FUNCTION; HEART PROTECTION; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACETYLCYSTEINE; AMIDINES; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZYLAMINES; CARDIOMYOPATHIES; CRICETINAE; DRUG INTERACTIONS; ENZYME INHIBITORS; FIBROSIS; FREE RADICAL SCAVENGERS; HEART; HEART VENTRICLES; LOSARTAN; MALE; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; ORGAN SIZE; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

CRICETINAE;

EID: 52949083141     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2069     Document Type: Article

References (34)

1. Anselm E, Chataigneau M, Ndiaye M, Chataigneau T, Schini-Kerth VB. Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src- and Akt-dependent activation of eNOS. Cardiovasc Res 73: 404-413, 2007.
2. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897-1918, 2001.
3. Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 80: 15L-25L, 1997.
4. Das M, Das S, and Das DK. Caveolin and MAP kinase interaction in angiotensin II preconditioning of the myocardium. J Cell Mol Med 11: 788-797, 2007.
5. Das DK, Maulik N, and Engelman RM. Redox regulation of angiotensin II signaling in the heart. J Cell Mol Med 8: 144-152, 2004.
6. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
7. Dresdale AR, Barr LH, Bonow RO, Mathisen DJ, Myers CE, Schwartz DE, d'Angelo T, and Rosenberg SA. Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy. Am J Clin Oncol 5: 657-663, 1982.
8. Escobales N and Crespo MJ. Angiotensin II-dependent vascular alterations in young cardiomyopathic hamsters: role for oxidative stress. Vascul Pharmacol 44: 22-28. 2006.
9. Fiordaliso F, Bianchi R, Staszewsky L, Cuccovillo I, Doni M, Laragione T, Salio M, Savino C, Melucci S, Santangelo F, Scanziani E, Masson S, Ghezzi P, and Latini R. Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. J Mol Cell Cardiol 37:959-968, 2004.
10. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, and Knowles RG. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272: 4959-4963, 1997.
11. Hausenloy DJ and Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 61: 448-460, 2004.
12. Kehrer JP and Lund LG. Cellular reducing equivalents and oxidative stress. Free Radic Biol Med 17: 65-75, 1994.
13. Kyoi S, Otani H, Matsuhisa S, Akita Y, Enoki C, Tatsumi K, Hattori R, Imamura H, Kamihata H, and Iwasaka T. Role of oxidative/nitrosative stress in the tolerance to ischemia/reperfusion injury in cardiomyopathic hamster heart. Antioxid Redox Signal 8: 1351-1361, 2006.
14. Massion PB and Balligand JL. Relevance of nitric oxide for myocardial remodeling. Curr Heart Fail Rep 4: 18-25, 2007.
15. Matsuhisa S, Otani H, Okazaki T, Yamashita K, Akita Y, Sato D, Moriguchi A, Imamura H, and Iwasaka T. Angiotensin II type-1 receptor blocker preserves tolerance to ischemia/reperfusion injury in Dahl salt-sensitive rat heart. Am J Physiol Heart Circ Physiol, in press.
16. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, and Puca GA. Identification of the Syrian hamster cardiomyopathy gene. Hum Mol Genet 6: 601-607, 1997.
17. Otani H. Reactive oxygen species as mediators of signal transduction in ischemic preconditioning. Antioxid Redox Signal 6: 449-469, 2004.
18. Otani H. Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 10: 207-48, 2008.
19. Oudit GY, Kassiri Z, Patel MP, Chappell M, Butany J, Backx PH, Tsushima RG, Scholey JW, Khokha R, and Penninger JM. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc Res 75: 29-39, 2007.
20. Paravicini TM, Miller AA, Drummond GR, and Sobey CG. Flow-induced cerebral vasodilatation in vivo involves activation of phosphatidylinositol-3 kinase, NADPH-oxidase, and nitric oxide synthase. J Cereb Blood Flow Metab 26: 836-845, 2006.
21. Parola M, Bellomo G, Robino G, Barrera G, and Dianzani MU. 4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. Antioxid Redox Signal 1: 255-284, 1999.
22. Penna C, Mancardi D, Rastaldo R, Losano G, and Pagliaro P. Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac post-conditioning through redox signaling. Cardiovasc Res 75: 168-177, 2007.
23. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
24. Privratsky JR, Wold LE, Sowers JR, Quinn MT, and Ren J. AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase. Hypertension 42: 206-212, 2003.
25. Rauchová H, Pechánová O, Kunes J, Vokurková M, Dobesová Z, and Zicha J. Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species. Hypertens Res 28:475-482, 2005.
26. Sadoshima J, Montagne O, Wang Q, Wang G, Warden J, Liu J, Takagi G, Karoor V, Hong C, Johnson GL, Vatner DE, and Vatner SF. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest 110: 271-279, 2002.
27. Sato M, Engelman RM, Otani H, Maulik N, Rousou JA, Flack JE 3rd, Deaton DW, and Das DK. Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation 102: III346-III351, 2000.
28. Savoia C, Ebrahimian T, He Y, Gratton JP, Schiffrin EL, and Touyz RM. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase. J Hypertens 24: 2417-2422, 2006.
29. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, and Hawkins PT. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate- dependent activation of protein kinase B. Science 279: 710-714, 1998.
30. Sun Y, Sumi D, and Kumagai Y. Serine 1179 phosphorylation of endothelial nitric oxide synthase caused by 2,4,6-trinitrotoluene through PI3K/Akt signaling in endothelial cells. Toxicol Appl Pharmacol 214: 55-60, 2006.
31. Theuer J, Dechend R, Muller DN, Park JK, Fiebeler A, Barta P, Ganten D, Haller H, Dietz R, and Luft FC. Angiotensin II induced inflammation in the kidney and in the heart of double transgenic rats. BMC Cardiovasc Disord 2: 1-12, 2002.
32. Whaley-Connell A, Govindarajan G, Habibi J, Hayden MR, Cooper SA, Wei Y, Ma L, Qazi M, Link D, Karuparthi PR, Stump C, Ferrario C, and Sowers JR. Angiotensin II-mediated oxidative stress promotes myocardial tissue remodeling in the transgenic (mRen2) 27 Ren2 rat. Am J Physiol Endocrinol Metab 2007 293: E355-E363, 2007.
33. Williams IA and Allen DG. The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 293: H1969-H1977, 2007.
34. Yang B and Rizzo V. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: H954-H962, 2007.